EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A ProTide of AZT Shows Activity Against Human Papillomaviruses

Tim Gniech, Adrian Humboldt, Kathy A Keith, Scott H James, Clemens Richert iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202300661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Tim Gniech und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry, University of Stuttgart, Pfaffenwaldring 55, 70569, Stuttgart, Germany. Hauptthemen laut MEDLINE: Papillomavirus Infections, Prodrugs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection by human papillomaviruses (HPV) can cause warts and tumors. So far, no small molecule antiviral has been approved for the treatment of infections with this DNA virus, although preclinical studies show activity for nucleosidic compounds, such as 9‐(2‐phosphonylmethoxy)ethylguanine (PMEG) or cidofovir. This prompted us to test new prodrug versions of the nucleoside analog 3’‐azido‐2’,3’‐dideoxythymidine (AZT), known to be active against reverse transcriptases and approved for the treatment of HIV. Here we report the synthesis of an ethylbutyl alaninyl ester phosphosphoramidate prodrug of AZT, dubbed AZAEB, and its activity against HPV, a target not known to be sensitive to AZT. A methyl ester derivative was found to be inactive against this and three other DNA viruses, while the phosphoramidate prodrug AZAEB showed a modest inhibitory effect against HPV types 6, 11, 18 and 31. Our results open up new avenues of study for the treatment of diseases caused by members of the papillomaviridae family.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsProdrugsHumansZidovudineProTidesHuman Papillomavirus VirusesNucleosidesEstersAntiviral Agents

Stichwörter der Autor:innen

Antiviralshuman papilloma virusnucleosidesnucleotidesprodrugs

Substanzen

ZidovudineProTidesNucleosidesProdrugsEstersAntiviral Agents

Autor:innen und Institutionen

  • Institute of Organic Chemistry, University of Stuttgart, Pfaffenwaldring 55, 70569, Stuttgart, Germany.
  • Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.

ORCID-Profile: Clemens Richert

Förderung

  • NIH HHS
  • HHS
  • NIAID NIH HHS
  • Deutsche Forschungsgemeinschaft
  • Volkswagen Foundation
  • Universität Stuttgart
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Gniech, T., Humboldt, A., Keith, K. A., James, S. H., & Richert, C. (2024). A ProTide of AZT Shows Activity Against Human Papillomaviruses. ChemMedChem. https://doi.org/10.1002/cmdc.202300661

Vancouver

Gniech T, Humboldt A, Keith KA, James SH, Richert C. A ProTide of AZT Shows Activity Against Human Papillomaviruses. ChemMedChem. 2024. doi:10.1002/cmdc.202300661

BibTeX
@article{Gniech2024,
  author = {Gniech, Tim and Humboldt, Adrian and Keith, Kathy A and James, Scott H and Richert, Clemens},
  title = {A ProTide of AZT Shows Activity Against Human Papillomaviruses},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202300661}
}
Kostenlos starten →